Robert Phelan Sells 2,186 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,186 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.15, for a total value of $295,437.90. Following the sale, the chief financial officer directly owned 48,306 shares of the company’s stock, valued at $6,528,555.90. This represents a 4.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 2.1%

Shares of NYSE:CVSA traded down $2.73 during mid-day trading on Tuesday, hitting $125.98. 329,097 shares of the company traded hands, compared to its average volume of 372,013. The stock has a market cap of $4.29 billion, a PE ratio of 17.89, a P/E/G ratio of 1.05 and a beta of 0.62. The firm’s 50-day moving average price is $124.82. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.09.

Adtalem Global Education (NYSE:CVSA) last posted its quarterly earnings data on Thursday, August 6th. The company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. The firm had revenue of $501.38 million for the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, analysts expect that Adtalem Global Education Inc. will post 8.95 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Truist Financial lifted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Barrington Research restated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. Finally, Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.